Proto Labs, Inc.
PRLB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.2% | 7% | 3.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.3% | 44.3% | 44.1% | 42.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.8% | 11.3% | 11.6% | 7% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 5.3% | 3.3% | 2.9% | -0.3% |
| EPS Diluted | 0.3 | 0.18 | 0.15 | -0.017 |
| % Growth | 66.7% | 20% | 1,009.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |